期刊文献+

骨髓间充质干细胞对大鼠到小鼠胰岛移植的保护作用 被引量:2

Bone Mesenchymal Stem Cells Induced Immunotolerance on Rat to Mouse Islet Transplantation
原文传递
导出
摘要 目的探讨同种异基因骨髓间充质干细胞(bone mesenchamal stem cells,BMSC)静脉输注对大鼠到小鼠胰岛移植物的功能保护和小鼠糖尿病状态改善。方法全骨髓培养法获得C57BL/6小鼠BMSC。不连续梯度离心法分离纯化Sprague-Dawley(SD)大鼠胰岛,将300胰岛当量的胰岛单独或与BMSC联合移植入链脲菌素诱导的糖尿病BALB/c小鼠肾包膜下,并通过尾静脉在移植后0、3和5d注射CM-DiI标记的BMSC 5×105/只,对照组给于磷酸盐缓冲溶液。移植后监测血糖,第9天处死小鼠,取肝、脾、胸腺、淋巴结和移植胰岛的肾脏,冰冻切片,荧光显微镜观察CM-DiI标记细胞的组织分布;免疫荧光法观察移植物中胰岛素和胰高血糖素表达,评价胰岛的功能。结果 BMSC静脉输注后主要分布于胸腺,其次是脾脏和淋巴结,肾和肝组织中未观察到BMSC;BMSC联合胰岛移植组血糖控制水平优于其他组,且在第7天的口服糖耐量实验优于单纯胰岛移植组。结论与胰岛联合移植的BMSC对受者免疫器官和组织有明显的趋向性,且对胰岛细胞的体内存活有一定保护作用。 Objective To research on the protection function by the allogeneic rat bone mesenchymal stem cells(BMSC) on rat to mouse islet transplantation and the improvement of diabetic state in mouse.Methods BMSC were prepared from C57BL/6 mouse bone marrow cells and identified by flow cytometry(FCM).Islets were isolated from Sprague-Dawley(SD) rats with Ficoll discontinuous centrifugation.CM-DiI labeled BMSC at 5×105 for one mouse were intravenously infused into STZ induced diabetic BALB/c mice after rat to mouse islet transplantation at day 0,3 and 5.Mice with PBS intravenously infused after islet transplantation were set as the negative controls.Blood glucose was monitored every day at the first 3 days after transplantation,and then monitored every two days.At day 9 after transplantation,spleen,thymus,lymph nods,liver and islets recipient kidney were harvested.Ice slices were prepared and CM-DiI labeled cells were investigated with fluorescence microscope.Results CM-DiI-labeled BMSC were mainly distributed in thymus followed by spleen and lymph nodes.In liver and kidney,there was no red fluorescence observed.The blood sugar control for combined BMSC infusion group was superior to other groups,and the control level of islet combined BMSC infusion group were better than single islet transplantation group in OGTT at day 7.Conclusion Allogeneic BMSC can sustain the insulin secretion of islets in vivo and tend to distribute in immune organs or adenoid tissues after infusion.
出处 《华西医学》 CAS 2011年第5期641-645,共5页 West China Medical Journal
基金 国家自然科学基金资助项目(30872382 30872528)~~
关键词 骨髓间充质干细胞 异种胰岛移植 免疫调节 Bone mesenchymal stem cells Xeno islet transplantation Immunotolerance
  • 相关文献

参考文献15

  • 1Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the edmonton protocol for islet transplantation[J]. N Engl J Med, 2006, 355(13): 1318-1330.
  • 2Nanii SA, Shapiro AM. Advances in pancreatic islet transplantation in humans[J]. Diabetes Obes Meta, 2006,8(1): 15-25.
  • 3Ryan EA, Paty BW, Senior PA, etal. Five-yearfollow-up after clinical islet transplantation [J].Diabetes, 2005, 54 (7): 2060-2069.
  • 4Frank A, Deng S, Huang X, et al. Transplantation for type- 1 diabetes comparison of vascularized whole-organ pancreas with isolated pancreatic islets[J]. Ann Surg, 2004, 240 (4): 631-643.
  • 5Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glueocorticoid-free immuno-suppressive regimen[J]. N Engl J Med, 2000, 343(3): 230-238.
  • 6D'Ippolito G, Diabira S, Howard GA, et al. Low oxygen tension inhibits osteogenic differentiation and enhances sternness of human MIAMI cells[J]. Bone, 2006, 39(3): 513-522.
  • 7Grayson WL, Zhao F, Izadpanah R, etal. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs[J]. J Cell Physiol, 2006, 207(2):331- 339.
  • 8Mclntosh K, Bartholomew A. Stromal cell modulation of the immune system[J]. Graft, 2000, 3(6): 324-328.
  • 9Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo[J]. Exp Hematol, 2002, 30 (1): 42 -48.
  • 10袁宇,丛聪,张静,魏玲玲,李胜富,金熙,麦刚,李幼平,程惊秋,陆燕蓉.大鼠胰岛的分离纯化方法改进与功能鉴定[J].中国修复重建外科杂志,2008,22(1):75-79. 被引量:14

二级参考文献21

  • 1李永翔,李戈,董维平,陈静,卢大儒,谭建明.大鼠胰岛分离纯化技术的改进[J].复旦学报(医学版),2006,33(2):266-268. 被引量:15
  • 2Kobayshi N, Okitsu T, Lakey, JR, et al. The current situation in human pancreatic islet transplantation: problems and prospects. J Artif Organs, 2004, 7: 1-8.
  • 3Ryan EA, Lakey JR, Rajotte RV. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes, 2001, 50(4): 710-719.
  • 4Ryan EA, Lakey, JR, Paty BW. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes, 2002, 51(7): 2148-2157.
  • 5Ren J, Jin P, Wang E, et al. Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation. J Transl Med, 2007, 5: 1.
  • 6Mathieu C. Limitations of islet transplantation. Transplant Proc, 2001, 33(1-2): 1707-1708.
  • 7Shapiro AM, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type Ⅰ diabetes mellitus using a glucocorticoid free immunosuppressive regimen. N Engl J Med, 2000, 343(4): 230-238.
  • 8Brendd MD, Hering BJ, Schultz AO, et al. International islet transplant registry. Newsletter, 2001, 8: 4.
  • 9Shapiro AM, Hao E, Rajotte RV, et al. High yield of rodent islets with intraductal collagenase and stationary digestion comparison with standard technique. Cell Transplant, 1996, 5(6): 631-638.
  • 10Kinasiewicz A, luszczak M, Pachecka J, et al. Pancreatic islets isolation using different protocols with in situ flushing and intraductal collage- nase injection. Physiol Res, 2004, 53(3): 327-333.

共引文献13

同被引文献56

  • 1高峰,蔡振杰,李利,郑奇军,刘维永.血管内皮生长因子基因转染骨髓间充质干细胞移植促进缺血心肌血管生成的研究[J].中国实用内科杂志:临床前沿版,2006,26(10):1600-1602. 被引量:6
  • 2Abdel Aziz MT, EI-Asmar MF, Haidara M, et al. Effect of bone marrow-derived mesenchymal stem cells on cardiovascular compli- cations in diabetic rats[ J]. Med Sci Monit ,2008,14 (11 ) : BR249- BR255.
  • 3Chen LB ,Jiang XB, Yang L. Differentiation of rat marrow mensen- chymal stem cells into pancreatic islet-cell [ J ]. World J Gastroen- terol, 2004,10 ( 20 ) : 3016 -3020.
  • 4Li L, Li F, Qi H, et al. Coexpression of Pdx-1 and betacellulin inmesenchymal stem cells could promote the differentiation of nestin- positive epithelium-like progenitors and pancreatic islet-like sphe- roids[ J]. Stem Cells Dev,2008,17(4) :815-823.
  • 5Aggarwal S, Pittenger MF. Human mesenchymal stem cells modu- late allogeneic immune cellresponses [ J ]. Blood, 2005,105 ( 4 ) : 1815-1822.
  • 6Tritt M, Sgouroudis E, D' Hennezel E, et al. Functional wanning of naturally occuring CD4 + regulatory T-cells contributes to the onset of autoimmune diabetes [ J ]. Diabetes,2008,57 ( 1 ) : 113-123.
  • 7Madec AM, Mallone R, A fonso G, et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells [J]. Diabetologia,2009,52(7) :1391-1399.
  • 8Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specif- ic T cells to their cognate peptide [ J ]. Blood,2003,101 (9) :3722- 3729.
  • 9Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not acti- vated cytotoxic T lymphocytes or natural killer cells [ J ]. Transplan- tation, 2003,76 ( 8 ) : 1208-1213.
  • 10Krampera M, Cosmi R, Angeli R, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesen- chymal stem cells[ J]. Stem Cells,2006,24(2) :386-398.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部